List of insiders holdings for Contineum Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. Versant Ventures IV LLC 10% Owner | 2024-04-11 18:10:57 | 3,539,761 6,562,151 | 10,101,912 | Form 4 |
JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 2024-04-10 17:12:55 | 1,979,173 0 | 1,979,173 | Form 13G |
Stengone Carmine N. CEO and President | 2024-05-29 17:59:53 | 285,000 0 | 285,000 | Form 4 |
Huhn Stephen L. CMO & Sr VP, Clinical Dev. | 2024-08-14 18:03:27 | 174,194 0 | 174,194 | Form 4 |
Lorrain Daniel S. Chief Scientific Officer | 2024-11-27 17:06:15 | 168,562 3,898 | 172,460 | Form 4 |
Healy John Stephen General Counsel and Corp Sec | 2024-06-03 17:46:32 | 160,000 0 | 160,000 | Form 4 |
Slover Peter T Chief Financial Officer | 2024-05-29 17:58:54 | 100,000 0 | 100,000 | Form 4 |
Schimmelpennink Evert B. Director | 2024-05-29 17:53:13 | 29,500 0 | 29,500 | Form 4 |
Brady Todd R. Director | 2024-05-29 17:54:17 | 29,500 0 | 29,500 | Form 4 |
Lyons-Williams Lori Director | 2024-05-29 17:54:56 | 29,500 0 | 29,500 | Form 4 |
Boyce Sarah Director | 2024-06-24 16:25:48 | 29,500 0 | 29,500 | Form 4 |
Ignelzi Troy A. Director | 2024-05-29 17:56:10 | 6,350 0 | 6,350 | Form 4 |
Ware Olivia C Director | 2024-05-29 17:55:33 | 3,700 0 | 3,700 | Form 4 |